Trial reportBMC anesthesiology2026
Effects of FiO2 adjustment on hyperoxia biomarkers and postoperative complications using oxygen reserve index during one-lung ventilation.
Trial report in BMC anesthesiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07359833 (Effects of FiO2 Adjustment on Hyperoxia Biomarkers and Postoperative Complications Using Oxygen Reserve Index During One-lung Ventilation), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Effects of FiO2 Adjustment on Hyperoxia Biomarkers and Postoperative Complications Using Oxygen Reserve Index During One-lung Ventilation
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOne-lung ventilation (OLV) is commonly used in thoracic surgery but increases the risk of intraoperative hypoxemia. To prevent hypoxia, high fractions of inspired oxygen (FiO₂) are frequently administered; however, excessive oxygen exposure may lead to hyperoxia and oxidative tissue injury. The Oxygen Reserve Index (ORi) is a non-invasive monitoring parameter that provides real-time information on moderate hyperoxia. This study aimed to evaluate whether ORi-guided oxygen titration reduces intraoperative FiO₂ exposure and influences oxidative stress biomarkers and postoperative outcomes in patients undergoing OLV.
methodsIn this prospective, randomized controlled trial, 60 patients undergoing elective thoracic surgery requiring OLV were allocated to either an ORi-guided group or a conventional oxygen management group. In the ORi group, FiO₂ was adjusted according to predefined ORi thresholds, whereas in the control group oxygen management was guided solely by pulse oximetry. The primary outcome was the mean intraoperative FiO₂ administered during OLV and throughout the entire surgery. Secondary outcomes included serum and tracheal aspirate levels of interleukin-6 (IL-6), superoxide dismutase (SOD), and malondialdehyde (MDA), postoperative pulmonary complications, and surgical site infections.
resultsMean intraoperative FiO₂ was significantly lower in the ORi group compared with the control group during OLV and across total surgery duration (p < 0.001). Oxygen saturation and ventilatory parameters were comparable between groups. Biomarker levels showed significant time-dependent changes; however, no significant differences were observed between groups, and no significant group × time interaction was detected. The incidence of postoperative pulmonary complications and surgical site infections did not differ between groups.
conclusionsORi-guided oxygen titration during OLV enables safe reduction of intraoperative FiO₂ while maintaining adequate oxygenation. Although this strategy did not translate into measurable differences in oxidative stress biomarkers or postoperative complications, these findings provide important clinical evidence regarding the physiological impact of moderate hyperoxia in thoracic surgery.
trial registrationClinicalTrials.gov identifier NCT07359833. First submission date: 17.01.2026 Retrospectively registered on 21.1.2026.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.